Company intelligence / Profile preview

Archimedes Vascular, Inc.

Birmingham, Alabama, United Statesarchimedesmedical.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Archimedes Vascular, Inc. is developing an implant for the treatment of severe hypertension and has recently closed a Series A financing round led by Sherpa Healthcare Partners. The company remains in the pre-clinical stage with no reported clinical results yet.

Therapeutic areas: Cardiovascular
Modalities: Implantable medical device
Industry: Implantable Medical Devices

Drug pipeline

1 asset

Barostent

Pre-clinical

Indications: Severe hypertension

Partnerships

Sherpa Healthcare Partners (lead investor in Series A)

Beyond the preview

Go deeper on Archimedes Vascular, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Archimedes Vascular, Inc..

Explore the full profile